KLRK1 and neoplasm: These cells recognize antigens in an MHC-independent manner (non-MHC restriction) via surface receptor NKG2D; clinical studies used allogeneic γδ T cells from healthy donors, since γδ T cells from the blood of tumor patients are sometimes difficult to expand in vitro.